SF3131 (Legislative Session 94 (2025-2026))
Commissioner of human services direction to establish a prescription drug purchasing program
Related bill: HF1093
AI Generated Summary
Purpose of the Bill
This bill aims to create a prescription drug purchasing program in Minnesota. The goal is to purchase prescription drugs at the lowest possible prices for individuals enrolled in Medical Assistance and MinnesotaCare.
Main Provisions
Establishment: The program will be overseen by Minnesota's commissioner of human services, targeting Medical Assistance and MinnesotaCare enrollees who are part of fee-for-service and managed care delivery systems.
Commissioner's Duties:
- The commissioner will be responsible for obtaining prescription drugs at low prices.
- The program is designed to promote health by providing discounted medication and coordinating comprehensive prescription benefits.
- A list of the most effective prescription drugs at the best prices will be maintained.
Program Authority:
- The commissioner has the authority, in consultation with the Formulary Committee, to adopt a preferred drug list.
- Engaging in price negotiations with drug manufacturers for discounts and rebates.
- Development and management of a drug formulary for the program.
Pharmacy Participation:
- The commissioner will set participation terms for pharmacies.
- All pharmacies participating as medical assistance providers, along with any willing and licensed pharmacies, can join the program under these terms.
Federal Approval:
- The program will seek necessary federal approvals to be implemented.
Significant Changes
This bill introduces a structured program aimed at reducing prescription drug costs through statewide purchasing and negotiation efforts, which could result in more affordable access to medications for eligible Minnesota residents.
Relevant Terms
- Prescription drug purchasing
- Medical Assistance
- MinnesotaCare
- Fee-for-service
- Managed care
- Preferred drug list
- Formulary
- Price negotiations
- Prescription drug manufacturers
- Drug formulary
- Federal approvals
Bill text versions
- Introduction PDF file
Actions
Date | Chamber | Where | Type | Name | Committee Name |
---|---|---|---|---|---|
March 31, 2025 | Senate | Floor | Action | Introduction and first reading | |
March 31, 2025 | Senate | Floor | Action | Referred to | Health and Human Services |